Low serum IGF-I/GH ratio is associated with abnormal glucose tolerance in acromegaly

Hormone Research

Volumn 69, Issue 3, 2008, Pages 165-171

  Fukuoka, Hidenori ^a   Takahashi, Yutaka ^a   Iida, Keiji ^a   Kudo, Takumi ^a   Nishizawa, Hitoshi ^a   Imanaka, Mari ^a   Takeno, Ryoko ^a   Iguchi, Genzo ^a   Takahashi, Kentaro ^a   Okimura, Yasuhiko ^b   Kaji, Hidesuke ^c   Chihara, Kazuo ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c UNIVERSITY OF HYOGO   (Japan)

Author keywords

Acromegaly; Diabetes mellitus; Glucose tolerance; Growth hormone; Insulin like growth factor I

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; ARTICLE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE METABOLISM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN SENSITIVITY; MALE; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE;

ACROMEGALY; ADULT; BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 38549128869     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000112590     Document Type: Article

References (42)

1. Melmed S, Ho K, Klibanski A, Reichlin S, Thorner M: Clinical review 75: recent advances in pathogenesis, diagnosis, and management of acromegaly. J Clin Endocrinol Metab 1995;80:3395-3402.
2. Kasayama S, Otsuki M, Takagi M, Saito H, Sumitani S, Kouhara H, Koga M, Saitoh Y, Ohnishi T, Arita N: Impaired beta-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients. Clin Endocrinol (Oxf) 2000;52:549-555.
3. Nabarro JD: Acromegaly. Clin Endocrinol (Oxf) 1987;26:481-512.
4. Biering H, Knappe G, Gerl H, Lochs H: Prevalence of diabetes in acromegaly and Cushing syndrome. Acta Med Austriaca 2000;27:27-31.
5. Kreze A, Kreze-Spirova E, Mikulecky M: Risk factors for glucose intolerance in active acromegaly. Braz J Med Biol Res 2001;34:1429-1433.
6. Moses AC, Young SC, Morrow LA, O'Brien M, Clemmons DR: Recombinant human insulin-like growth factor I increases insulin sensitivity and improves glycemic control in type II diabetes. Diabetes 1996;45:91-100.
7. Yakar S, Setser J, Zhao H, Stannard B, Haluzik M, Glatt V, Bouxsein ML, Kopchick JJ, LeRoith D: Inhibition of growth hormone action improves insulin sensitivity in liver IGF-1-deficient mice. J Clin Invest 2004;113:96-105.
8. Clemmons DR: Roles of insulin-like growth factor-I and growth hormone in mediating insulin resistance in acromegaly. Pituitary 2002;5:181-183.
9. O'Connell T, Clemmons DR: IGF-I/IGF-binding protein-3 combination improves insulin resistance by GH-dependent and independent mechanisms. J Clin Endocrinol Metab 2002;87:4356-4360.
10. Clemmons DR, Van Wyk JJ, Ridgway EC, Kliman B, Kjellberg RN, Underwood LE: Evaluation of acromegaly by radioimmunoassay of somatomedin-C. N Engl J Med 1979;301:1138-1142.
11. Puder JJ, Nilavar S, Post KD, Freda PU: Relationship between disease-related morbidity and biochemical markers of activity in patients with acromegaly. J Clin Endocrinol Metab 2005;90:1972-1978.
12. Manelli F, Bossoni S, Burattin A, Doga M, Solerte SB, Romanelli G, Giustina A: Exercise-induced microalbuminuria in patients with active acromegaly: acute effects of slow-release lanreotide, a long-acting somatostatin analog. Metabolism 2000;49:634-639.
13. Kuzuya T, Nakagawa S, Satoh J, Kanazawa Y, Iwamoto Y, Kobayashi M, Nanjo K, Sasaki A, Seino Y, Ito C, Shima K, Nonaka K, Kadowaki T: Report of the committee on the classification and diagnostic criteria of diabetes mellitus. Diabetes Res Clin Pract 2002;55:65-85.
14. Parkinson C, Ryder WD, Trainer PJ: The relationship between serum GH and serum IGF-I in acromegaly is gender-specific. J Clin Endocrinol Metab 2001;86:5240-5244.
15. Chang AM, Smith MJ, Bloem CJ, Galecki AT, Halter JB, Supiano MA: Limitation of the homeostasis model assessment to predict insulin resistance and beta-cell dysfunction in older people. J Clin Endocrinol Metab 2006;91:629-634.
16. Ferrannini E, Gastaldelli A, Miyazaki Y, Matsuda M, Mari A, DeFronzo RA: Beta-cell function in subjects spanning the range from normal glucose tolerance to overt diabetes: a new analysis. J Clin Endocrinol Metab 2005;90:493-500.
17. Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M: Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 2000;23:57-63.
18. Hermans MP, Levy JC, Morris RJ, Turner RC: Comparison of tests of beta-cell function across a range of glucose tolerance from normal to diabetes. Diabetes 1999;48:1779-1786.
19. Kanauchi M, Nakajima M, Saito Y, Kanauchi K: Pancreatic beta-cell function and insulin sensitivity in Japanese subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes mellitus. Metabolism 2003;52:476-481.
20. Thissen JP, Ketelslegers JM, Underwood LE: Nutritional regulation of the insulin-like growth factors. Endocr Rev 1994;15:80-101.
21. Jones JI, Clemmons DR: Insulin-like growth factors and their binding proteins: biological actions. Endocr Rev 1995;16:3-34.
22. Colao A, Amato G, Pedroncelli AM, Baldelli R, Grottoli S, Gasco V, Petretta M, Carella C, Pagani G, Tambura G, Lombardi G: Gender- and age-related differences in the endocrine parameters of acromegaly. J Endocrinol Invest 2002;25:532-538.
23. Dills DG, Allen C, Palta M, Zaccaro DJ, Klein R, D'Alessio D: Insulin-like growth factor-i is related to glycemic control in children and adolescents with newly diagnosed insulin-dependent diabetes. J Clin Endocrinol Metab 1995;80:2139-2143.
24. Tan K, Baxter RC: Serum insulin-like growth factor i levels in adult diabetic patients: the effect of age. J Clin Endocrinol Metab 1986;63:651-655.
25. Winter RJ, Phillips LS, Klein MN, Traisman HS, Green OC: Somatomedin activity and diabetic control in children with insulin-dependent diabetes. Diabetes 1979;28:952-954.
26. Amiel SA, Sherwin RS, Hintz RL, Gertner JM, Press CM, Tamborlane WV: Effect of diabetes and its control on insulin-like growth factors in the young subject with type I diabetes. Diabetes 1984;33:1175-1179.
27. Edge JA, Dunger DB, Matthews DR, Gilbert JP, Smith CP: Increased overnight growth hormone concentrations in diabetic compared with normal adolescents. J Clin Endocrinol Metab 1990;71:1356-1362.
28. Ekman B, Nystrom F, Arnqvist HJ: Circulating IGF-I concentrations are low and not correlated to glycaemic control in adults with type 1 diabetes. Eur J Endocrinol 2000;143:505-510.
29. Russell-Jones DL, Rattray M, Wilson VJ, Jones RH, Sonksen PH, Thomas CR: Intraperitoneal insulin is more potent than subcutaneous insulin at restoring hepatic insulin-like growth factor-I mRNA levels in the diabetic rat: a functional role for the portal vascular link. J Mol Endocrinol 1992;9:257-263.
30. Sonksen PH, Russell-Jones D, Jones RH: Growth hormone and diabetes mellitus: a review of sixty-three years of medical research and a glimpse into the future? Horm Res 1993;40:68-79.
31. Wurzburger MI, Prelevic GM, Sonksen PH, Wheeler M, Balint-Peric L: Effect of recombinant human growth hormone treatment on insulin-like growth factor (IGF-I) levels in insulin-dependent diabetic patients. Acta Diabetol 1995;32:131-134.
32. Hussain MA, Schmitz O, Mengel A, Keller A, Christiansen JS, Zapf J, Froesch ER: Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans. J Clin Invest 1993;92:2249-2256.
33. Woodhouse LJ, Mukherjee A, Shalet SM, Ezzat S: The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults. Endocr Rev 2006;27:287-317.
34. Ong KK, Petry CJ, Emmett PM, Sandhu MS, Kiess W, Hales CN, Ness AR, Dunger DB: Insulin sensitivity and secretion in normal children related to size at birth, postnatal growth, and plasma insulin-like growth factor-I levels. Diabetologia 2004;47:1064-1070.
35. Kulkarni RN, Holzenberger M, Shih DQ, Ozcan U, Stoffel M, Magnuson MA, Kahn CR: Beta-cell-specific deletion of the Igf1 receptor leads to hyperinsulinemia and glucose intolerance but does not alter beta-cell mass. Nat Genet 2002;31:111-115.
36. Xuan S, Kitamura T, Nakae J, Politi K, Kido Y, Fisher PE, Morroni M, Cinti S, White MF, Herrera PL, Accili D, Efstratiadis A: Defective insulin secretion in pancreatic beta cells lacking type 1 IGF receptor. J Clin Invest 2002;110:1011-1019.
37. LeRoith D, Clemmons D, Nissley P, Rechler MM: NIH conference. Insulin-like growth factors in health and disease. Ann Intern Med 1992;116:854-862.
38. Clemmons DR, Van Wyk JJ: Factors controlling blood concentration of somatomedin C. Clin Endocrinol Metab 1984;13:113-143.
39. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, Furlanetto R, Rogol AD, Kaiser DL, Thorner MO: Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 1987;64:51-58.
40. Dall R, Longobardi S, Ehrnborg C, Keay N, Rosen T, Jorgensen JO, Cuneo RC, Boroujerdi MA, Cittadini A, Napoli R, Christiansen JS, Bengtsson BA, Sacca L, Baxter RC, Basset EE, Sonksen PH: The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. Gh-2000 study group. J Clin Endocrinol Metab 2000;85:4193-4200.
41. van den Berg G, Veldhuis JD, Frolich M, Roelfsema F: An amplitude-specific divergence in the pulsatile mode of growth hormone (GH) secretion underlies the gender difference in mean GH concentrations in men and premenopausal women. J Clin Endocrinol Metab 1996;81:2460-2467.
42. Vaessen N, Heutink P, Janssen JA, Witteman JC, Testers L, Hofman A, Lamberts SW, Oostra BA, Pols HA, van Duijn CM: A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 2001;50:637-642.